WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
about
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulatorsIncreased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanismMethylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancersSecreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancerThe Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomasThe Wnt-dependent signaling pathways as target in oncology drug discoveryWnt signalling via the epidermal growth factor receptor: a role in breast cancer?Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerDifferential impact of tumor suppressor pathways on DNA damage response and therapy-induced transformation in a mouse primary cell modelSmall molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancerTranscriptional regulation of the promoter of the rat frizzled related protein gene by CREBThe Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesisThe Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.Signalling pathways implicated in early mammary gland morphogenesis and breast cancer.Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinomaGene expression profiling of the tumor microenvironment during breast cancer progression.MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumorsMolecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.Wnt1 expression induces short-range and long-range cell recruitments that modify mammary tumor development and are not induced by a cell-autonomous beta-catenin effectorMammary development and breast cancer: the role of stem cellsEffects of EpCAM overexpression on human breast cancer cell linesWnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model.Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.Hypermethylation and aberrant expression of Wnt antagonist secreted frizzled-related protein 1 in gastric cancerWnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells.Differential expression of centrosome regulators in Her2+ breast cancer cells versus non-tumorigenic MCF10A cells.MENA is a transcriptional target of the Wnt/beta-catenin pathway.Wnt and mammary stem cells: hormones cannot fly wingless.The transcripts of SFRP1,CEP63 and EIF4G2 genes are frequently downregulated in transitional cell carcinomas of the bladder.Targeting breast stem cells with the cancer preventive compounds curcumin and piperine.Key signaling nodes in mammary gland development and cancer: β-catenin.Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.Expression of SFRP Family Proteins in Human Keratoconus Corneas.Secreted Frizzled-related proteins: searching for relationships and patterns.Breast cancer, stem cells and prospects for therapy.BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanomaThe Wnt antagonist sFRP1 as a favorable prognosticator in human biliary tract carcinoma.
P2860
Q24303946-CC281A52-D284-4C3F-8EFB-3459B428B61CQ24305585-1914723D-31C8-457E-823A-6CA6E5840FF6Q24309483-727F0EAF-8626-435D-8582-8B87D18331A9Q24319970-50FE1108-D079-4C46-92FF-931B02EE164EQ24651437-36FD4B67-2C1A-4F38-9C09-E56B5DBE81F3Q24652979-0F3A1C26-807A-430B-92DE-28BD2ED08701Q24794064-FBC92E37-B01A-4F72-8FF9-DCE2BBE14719Q28245608-11CEFB7D-F38B-455C-B0D1-15A66C0FB211Q28472388-73547BC2-CBAC-49E4-847F-7CD8927FC3BBQ28481728-FD1FEB67-A072-4AC3-8016-0D21BCB6283DQ28583905-916EEF86-6C63-4375-8385-DBC87D580254Q28589724-6BF530BD-9814-4DF4-8887-363FAEABBAA1Q30978083-AF955865-6834-4AB9-B050-B5A0EADA4976Q33255332-3605D9C1-CCD0-4DA0-9453-6E0F6B7B623EQ33290638-82E4F681-6FF9-47EA-8F02-7FE6F9D6D0EBQ33404889-5321A104-EEE5-45BC-A35E-AA9AFB9A6F57Q33410269-4DBFB8CA-9315-4388-87A5-9E503D910260Q33559178-A38028D2-1E1E-4301-B6E4-0FF8E61E069CQ33618690-15D9BA69-DEB7-4146-9ECE-9F976601BCBCQ33682678-559274A9-1C24-46CD-98C4-4014E5D44357Q33735595-4D9FC7EF-E602-4A3D-8EA9-E6A48A19ABA9Q33807783-01E3FF98-3928-4839-917F-0DC38B3C9FEDQ33867838-B217BE6D-80EB-48AD-83EF-750D04D92D64Q33902551-973CE8B4-2A3F-4CE3-96FC-A21B3A003693Q34048070-61B40713-F727-44ED-84AE-0A971E3B3B4FQ34098916-BDE973B5-29AA-4263-9FC1-DA90E17F7392Q34227971-B1F3F75C-8806-44E9-9099-8CD776951BCCQ34273997-2CCCABE3-6B8B-4A8C-80A1-6D2B154E6334Q34277630-9303C488-B653-4541-861F-7EBC537A6B1DQ34311270-8D62FDAF-92CE-45C9-88F0-572866ABA167Q34484329-14C50B2D-FAD4-418F-B234-69381D8131D6Q34574742-12B90F58-9611-4EE4-B347-53FDE763F823Q34613461-AFF2C653-ED2B-42EC-8F4A-807DCDD72972Q34630473-DC712D47-0E62-438C-A1BC-76ED904415B6Q34793735-1A5C6536-2E2F-45A1-9840-DF3FF07C6000Q34811402-7B0B42F0-7770-4C3C-B4C6-9A1D7E151695Q35012847-01C8DB7E-5268-43DF-8EFD-59299F116B6BQ35063960-79384B02-B0F8-4F9D-BABE-3E63CB84F56EQ35091482-48BA3C83-F347-4FCA-8B1F-05D15D71229CQ35110848-C6FFB409-CD40-4E2B-8D4F-72FDE198A692
P2860
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
WNT pathway and mammary carcin ...... s except of the medullary type
@ast
WNT pathway and mammary carcin ...... s except of the medullary type
@en
WNT pathway and mammary carcin ...... s except of the medullary type
@nl
type
label
WNT pathway and mammary carcin ...... s except of the medullary type
@ast
WNT pathway and mammary carcin ...... s except of the medullary type
@en
WNT pathway and mammary carcin ...... s except of the medullary type
@nl
prefLabel
WNT pathway and mammary carcin ...... s except of the medullary type
@ast
WNT pathway and mammary carcin ...... s except of the medullary type
@en
WNT pathway and mammary carcin ...... s except of the medullary type
@nl
P2093
P2860
P3181
P356
P1433
P1476
WNT pathway and mammary carcin ...... s except of the medullary type
@en
P2093
D Birnbaum
E Charafe-Jauffret
F Labat-Moleur
J Adélaïde
J Jacquemier
M J Pébusque
V J Bardou
P2860
P2888
P304
P3181
P356
10.1038/SJ.ONC.1204706
P407
P577
2001-09-13T00:00:00Z
P5875
P6179
1033920615